This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (88)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

F. Blaine Hollinger, MD; Narayan C. Khan, PhD; Paul E. Oefinger, PhD; David H. Yawn, MD; A. Carl Schmulen, MD; Gordon R. Dreesman, PhD; Joseph L. Melnick, PhD

JAMA. 1983;250(17):2313-2317.

Abstract
Hepatitis A virus (HAV) transmission through blood is a rare but potential cause of posttransfusion hepatitis. We can now document such a case supported by laboratory evidence of HAV in the donor blood. A 10-year-old girl manifested icteric hepatitis A 31 days after receiving a single unit of packed RBCs from a donor who subsequently experienced hepatitis A and died in hepatic failure. Hepatitis A virus antigen was detected in the donor's hepatocytes and in plasma obtained from the original donor unit. The density in cesium chloride of the HAV antigenic activity from the liver and plasma ranged from 1.33 to 1.37 g/cu cm, which is similar to that reported for infectious HAV particles. The implicated donor plasma had normal aminotransferase levels and was negative for antibody to HAV. Inoculation of this plasma into a chimpanzee resulted in the development of hepatitis A 23 days later based on the appearance of fecal HAV antigen, hepatitis, and IgM anti-HAV seroconversion. These data clearly document the presence of HAV in the donor sample that produced posttransfusion hepatitis A.

(JAMA 1983;250:2313-2317)

Author Affiliations
From the Departments of Virology and Epidemiology (Drs Hollinger, Khan, Oefinger, Dreesman, and Melnick), Medicine (Dr Schmulen), and Pathology (Dr Yawn), Baylor College of Medicine, Houston.

Footnotes
Reprint requests to Department of Virology and Epidemiology, Baylor College of Medicine, Houston, TX 77030 (Dr Hollinger).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fulminant Hepatitis A in Intravenous Drug Users with Chronic Liver Disease
Akriviadis and Redeker
ANN INTERN MED 1989;110:838-839.
ABSTRACT  

Transfusion-Acquired Hepatitis A in a Premature Infant With Secondary Nosocomial Spread in an Intensive Care Nursery
Azimi et al.
Arch Pediatr Adolesc Med 1986;140:23-27.
ABSTRACT  

Nosocomial Hepatitis A
GOODMAN
ANN INTERN MED 1985;103:452-454.
ABSTRACT  

Avoiding Infection From Blood Transfusion in Neonatal Units
Novak
JAMA 1985;253:2361-2362.
ABSTRACT  

Posttransfusion Hepatitis A in a Neonatal Intensive Care Unit
Noble et al.
JAMA 1984;252:2711-2715.
ABSTRACT  

Hepatitis A in Neonatal Care Units: Not Rare Enough?
Grady
JAMA 1984;252:2755-2755.
ABSTRACT  

Transmission of Hepatitis A by Transfusion of Blood Products
Sherertz et al.
Arch Intern Med 1984;144:1579-1580.
ABSTRACT